Hemopathy prognosis method
US10961588B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 26, 2015 |
| Grant date | Mar 30, 2021 |
| Priority date | — |
| Expiry date | Jul 28, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention relates to an in vitro method for prognosis of the response to a chemotherapy of an individual suffering from chronic myeloid leukemia, comprising a. a step of measuring the expression level of at least one subgroup of genes chosen from a group of genes, b. a comparing step, and c. a step of determining a score S such that—if S is less than 1, said individual will have more than a 40% chance of responding to the chemotherapy, and—if S is greater than or equal to 1, said individual will have less than a 40% chance of responding to the chemotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.